- Home
- BL vs BHC Comparison
BL vs BHC Comparison
Compare BL & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BL | BHC |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2016 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BL | BHC |
|---|---|---|
| Price | $28.44 | $5.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 3 |
| Target Price | ★ $56.62 | $8.00 |
| AVG Volume (30 Days) | 1.5M | ★ 1.7M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ 0.13 | N/A |
| Revenue | $177,031,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $12.62 | $4.61 |
| Revenue Next Year | $10.90 | N/A |
| P/E Ratio | $220.85 | ★ N/A |
| Revenue Growth | ★ 43.78 | N/A |
| 52 Week Low | $24.70 | $4.76 |
| 52 Week High | $59.57 | $8.69 |
Technical Indicators
Market Signals| Indicator | BL | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 45.60 | 45.73 |
| Support Level | $25.49 | $4.93 |
| Resistance Level | $30.93 | $6.31 |
| Average True Range (ATR) | 1.96 | 0.20 |
| MACD | 0.21 | -0.02 |
| Stochastic Oscillator | 41.75 | 49.28 |
Price Performance
Historical ComparisonAbout BL BlackLine Inc.
BlackLine Inc is engaged in providing financial accounting close solutions delivered as Software as a Service (SaaS). The Company's solutions enable its customers to address various aspects of their critical processes, including financial close & consolidation, intercompany accounting, and invoice-to-cash. The majority of the revenue of the company is earned in the United States.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.